Seelos Therapeutics Stock Price Prediction

SEEL Stock  USD 0.39  0.11  22.00%   
The value of RSI of Seelos Therapeutics' share price is below 30 as of now. This usually implies that the otc stock is becoming oversold or undervalued. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Seelos Therapeutics, making its price go up or down.

Oversold Vs Overbought

26

 
Oversold
 
Overbought
Seelos Therapeutics stock price prediction is an act of determining the future value of Seelos Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Seelos Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Seelos Therapeutics and does not consider all of the tangible or intangible factors available from Seelos Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Seelos Therapeutics, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Seelos Therapeutics based on different types of headlines from major news networks to social media. Using Seelos Therapeutics hype-based prediction, you can estimate the value of Seelos Therapeutics from the perspective of Seelos Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Seelos Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Seelos Therapeutics to buy its otc stock at a price that has no basis in reality. In that case, they are not buying Seelos because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell otc stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Seelos Therapeutics after-hype prediction price

    
  USD 0.39  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Seelos Therapeutics Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Seelos Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.020.3713.87
Details
Naive
Forecast
LowNextHigh
0.000075013.51
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.300.440.58
Details

Seelos Therapeutics After-Hype Price Prediction Density Analysis

As far as predicting the price of Seelos Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Seelos Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Seelos Therapeutics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Seelos Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting Seelos Therapeutics' otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Seelos Therapeutics' historical news coverage. Seelos Therapeutics' after-hype downside and upside margins for the prediction period are 0.02 and 13.89, respectively. We have considered Seelos Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.39
0.39
After-hype Price
13.89
Upside
Seelos Therapeutics is out of control at this time. Analysis and calculation of next after-hype price of Seelos Therapeutics is based on 3 months time horizon.

Seelos Therapeutics OTC Stock Price Prediction Analysis

Have you ever been surprised when a price of a OTC Stock such as Seelos Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Seelos Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Seelos Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  3.13 
13.50
 0.00  
  0.17 
0 Events / Month
14 Events / Month
Within a week
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.39
0.39
0.00 
0.00  
Notes

Seelos Therapeutics Hype Timeline

Seelos Therapeutics is at this time traded for 0.39. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.17. Seelos is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at -3.13%. %. The volatility of related hype on Seelos Therapeutics is about 24230.77%, with the expected price after the next announcement by competition of 0.56. The company recorded earning per share (EPS) of 351.04. Seelos Therapeutics last dividend was issued on the 24th of January 2019. The entity had 1:16 split on the 27th of September 2024. Given the investment horizon of 90 days the next forecasted press release will be within a week.
Check out Seelos Therapeutics Basic Forecasting Models to cross-verify your projections.

Seelos Therapeutics Related Hype Analysis

Having access to credible news sources related to Seelos Therapeutics' direct competition is more important than ever and may enhance your ability to predict Seelos Therapeutics' future price movements. Getting to know how Seelos Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Seelos Therapeutics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
ATAIATAI Life Sciences 0.05 5 per month 3.55  0.06  11.01 (6.56) 25.61 
MNMDMind Medicine(0.18)9 per month 3.75  0.07  9.76 (5.78) 24.75 
GHRSGH Research PLC(0.12)6 per month 0.00 (0.06) 8.59 (6.57) 26.09 
FRLNFreeline Therapeutics Holdings(0.58)1 per month 0.00 (0.02) 14.23 (13.11) 72.38 
CYBNCybin Inc 0.45 4 per month 4.00 (0.01) 9.30 (7.40) 24.94 
AWKNFAwakn Life Sciences 0.00 0 per month 11.41  0.05  19.14 (23.93) 93.51 
PULMPulmatrix 1.01 3 per month 3.26  0.18  12.29 (4.76) 92.85 
CAPRCapricor Therapeutics(0.08)11 per month 4.10  0.23  18.22 (7.37) 69.31 
AKTXAkari Therapeutics PLC 0.22 5 per month 0.00 (0.24) 4.84 (12.30) 47.27 
DFFNDiffusion Pharmaceuticals 0.1 5 per month 0.00 (0.21) 4.09 (5.32) 12.34 
SLNOSoleno Therapeutics 0.67 10 per month 2.49  0.06  6.31 (4.12) 13.33 
ELYMEliem Therapeutics 0.25 4 per month 0.00 (0.20) 6.21 (9.35) 34.87 
OPTOpthea 0.11 11 per month 3.89  0.02  8.65 (7.49) 24.20 
MOLNMolecular Partners AG(0.10)5 per month 0.00 (0.03) 9.61 (8.53) 52.92 
EWTXEdgewise Therapeutics 0.32 10 per month 2.85  0.11  6.65 (4.70) 61.02 
ITOSIteos Therapeutics(0.44)7 per month 0.00 (0.26) 4.26 (4.52) 33.24 
TCONTRACON Pharmaceuticals(0.01)8 per month 0.00 (0.18) 19.59 (17.77) 52.05 
HSTOHistogen 0.00 0 per month 0.00 (0.12) 4.76 (4.55) 131.40 
ENTXEntera Bio(0.03)4 per month 0.00 (0.04) 5.47 (5.47) 29.16 
TPSTTempest Therapeutics(0.47)4 per month 0.00 (0.14) 6.38 (8.53) 29.55 
BTTXBetter Therapeutics 0.00 0 per month 0.00 (0.14) 12.64 (9.62) 36.53 

Seelos Therapeutics Additional Predictive Modules

Most predictive techniques to examine Seelos price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Seelos using various technical indicators. When you analyze Seelos charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Seelos Therapeutics Predictive Indicators

The successful prediction of Seelos Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Seelos Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Seelos Therapeutics based on analysis of Seelos Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Seelos Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Seelos Therapeutics's related companies.

Story Coverage note for Seelos Therapeutics

The number of cover stories for Seelos Therapeutics depends on current market conditions and Seelos Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Seelos Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Seelos Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Seelos Therapeutics Short Properties

Seelos Therapeutics' future price predictability will typically decrease when Seelos Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Seelos Therapeutics often depends not only on the future outlook of the potential Seelos Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Seelos Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding4.9 M
Cash And Short Term InvestmentsM

Other Information on Investing in Seelos OTC Stock

Seelos Therapeutics financial ratios help investors to determine whether Seelos OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Seelos with respect to the benefits of owning Seelos Therapeutics security.